• Health Care Enforcement Review and 2017 Outlook: Part 3
  • March 10, 2017 | Authors: Jordan T. Cohen; Laurence J. Freedman; Karen S. Lovitch
  • Law Firm: Mintz Levin Cohn Ferris Glovsky Popeo P.C. - Boston Office
  • Law 360, New York (January 18, 2017, 12:37 PM EST) - In part 1 of this four-part series, we examined the U.S. Food and Drug Administration’s wide-ranging enforcement activities related to health care fraud. In part 2 we discussed 2016’s major case developments in health care enforcement. Part 3 will address significant regulatory developments in this area.